No it was not. For the six months ended June 30, 2014, Amarin reported a net loss of $10.7 million, or basic and diluted loss per share of $0.06 and 0.07, respectively.
Been no good news with AMRN for almost a year now. Today, the silence is deafening. Gotta believe there will be no major news today, other than earnings from Marine sales. When enough people have died, the FDA will do the right thing.